As a key mitotic cyclin, cyclin B1 induces the G2/M phase transition of the cell cycle, thus reducing the radiosensitivity in several types of cancers, such as nasopharyngeal carcinoma, squamous cell carcinoma, and non-small cell lung cancer [56–58]. Here, CCNB1 is linked to non-small cell lung carcinoma.